$2.64 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 7 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CERE | New | CEREVAL THERAPEUTICS HOLDINGS, INC | $1,005,284,000 | – | 60,632,356 | +100.0% | 38.09% | – |
| SGRY | SURGERY PARTNERS INC | $767,478,000 | +32.5% | 26,455,651 | 0.0% | 29.08% | -38.6% | |
| MIK | MICHAELS COS INC | $686,914,000 | +34.7% | 52,798,929 | 0.0% | 26.03% | -37.5% | |
| IQV | IQVIA HLDGS INC | $110,635,000 | +13.7% | 617,484 | 0.0% | 4.19% | -47.3% | |
| ADV | New | ADVANTAGE SOLUTIONS INC. | $38,061,000 | – | 2,890,000 | +100.0% | 1.44% | – |
| VRTV | Sell | VERITIV CORP | $28,770,000 | -18.4% | 1,383,840 | -50.3% | 1.09% | -62.2% |
| ATTO | ATENTO S A | $2,129,000 | +47.6% | 156,574 | 0.0% | 0.08% | -31.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners X, L.P. #1
- Bain Capital Fund X, L.P. #2
- Bain Capital Integral Investors 2008, L.P. #3
- Bain Capital Partners Europe III, L.P. #4
- Bain Capital Europe Fund III, L.P. #5
- Bain Capital Integral Investors 2006, LLC #6
- Atalaya Luxco S.a.r.l. #7
- Atalaya Luxco Topco S.C.A. #8
- Atalaya PIKco S.a r.l. #9
- Atalaya Luxco PIKco S.C.A #10
- BCPE Seminole GP LLC #11
- BCPE Seminole Holdings LP #12
- Bain Capital Partners XII, LLC #13
- Bain Capital Fund XII, LP #14
- BCPE Perception GP, LLC #15
- BC Perception Holdings, LP #16
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.